Transducin-like enhancer protein 1 (TLE1) is a protein that is encoded by the TLE1 gene family and involved in control of hematopoiesis, neuronal, and terminal epithelial differentiation. Expression of the TLE genes (TLE1, TLE2, TLE3 and TLE4) correlates with immature epithelial cells that are progressing toward a terminally differentiated state, suggesting a role during epithelial differentiation. Anti-TLE1 antibody is a sensitive and specific marker for synovial sarcoma than other markers including BCL2, epithelial membrane antigen (EMA) and cytokeratins. It is used to differentiate synovial sarcoma from other sarcomas, including histologically similar tumors such as malignant peripheral nerve sheath tumor.
|Tissue Type/Cancer Type||
1 mL – Manual – Concentrate, 0.5 mL – Manual – Concentrate, 6 mL – Manual – RTU, 10 mL – Manual – RTU, 50 Tests – Automation – Xmatrx, 50 tests – NanoVIP, 160 Tests – Automation – Xmatrx